In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, researchers have identified a vulnerability that opens ...

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

The management of chronic hepatitis B (CHB) during pregnancy remains a challenge ... should be reserved for mothers with advanced disease or who are at risk for hepatic decompensation.

Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...

The NHS will automatically test patients for HIV, Hepatitis B and Hepatitis C unless they opt out at almost 90 Accident and Emergency (A&E) units in England, the BBC can reveal. The government is ...

The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Public Storage Dep. Pfd. (Rep. 1/1000th Share 3.875% Cum. Pfd. Series N)-0.30% Public Storage Dep. Pfd. (Rep. 1/1000th 4.7% Cum. Pfd. SBI Series J)-0.10% Public Storage Dep. Pfd. (Rep. 1/1000 ...